Cidofovir (CDV) is one of the most effective anti-orthopoxvirus drugs and it is 2 widely accepted that viral DNA replication is the main target of its activity. In the present 3 study, we report a detailed analysis of CDV effects on the replicative cycle of distinct 4 vaccinia virus (VACV) strains: Cantagalo virus, VACV-IOC and VACV-WR. We show 5 that despite the inhibition of virus progeny production by approximately 90%, virus DNA 6 accumulation was reduced only 30%, and late gene expression and genome resolution were 7 unaltered. Proteolytic cleavage of the major core proteins was diminished in CDV-treated 8 cells. Electron microscopic analysis of virus-infected cells in the presence of CDV revealed 9 up to 3.5-fold reduction in the number of mature forms of virus particles along with a 3.2-10 fold increase in the number of spherical immature particles. A detailed analysis of purified 11 virions recovered from CDV-treated cells demonstrated the accumulation of unprocessed 12 p4a and p4b and nearly 67% inhibition of DNA encapsidation. However, these effects of 13 CDV on virus morphogenesis resulted from a primary effect on virus DNA synthesis, 14 which led to later defects in genome encapsidation and virus assembly. Analysis of virus 15 DNA by atomic force microscopy (AFM) revealed that viral cytoplasmic DNA synthesized 16 in the presence of CDV had an altered structure, forming aggregates with increased strand 17 overlapping not observed in the absence of the drug. These aberrant DNA aggregations 18
INTRODUCTION 1
Vaccinia virus (VACV) is the prototypical member of the Poxviridae, a family of 2 large DNA-containing viruses. During infection, a cascade of temporally regulated viral 3 gene expression occurs exclusively in the cell cytoplasm, where viral DNA replication 4 takes place. DNA replication is essential for the onset of the intermediate and late steps of 5 viral gene expression (37). VACV morphogenesis is a complex process that starts within 6 the virus factories or virosomes in parallel with the late stage of gene expression. Virus 7 crescent-shaped membranes evolve into immature spherical particles (IV) that subsequently 8 progress to form brick-shaped mature virions (MV) (reviewed in reference 8). Virus 9 assembly and maturation are complex processes requiring telomere resolution of newly 10 replicated DNA (20, 36, 40) , genome encapsidation (6, 22, 50) , and the proteolytic 11 processing of major structural proteins (38, 51) . For the last decade, several reports have 12 analyzed in detail these numerous steps of VACV morphogenesis, unraveling the role of 13 distinct virus late proteins in the progression of viral particle formation (reviewed in 14 reference 8). 15
Cantagalo virus (CTGV) is a strain of VACV isolated from pustular lesions on cows 16 in Brazil (10). Similar outbreaks of vaccinia-like viruses have been reported frequently over 17 the last eight years (14, 39, 48) . Interestingly, the majority of these vaccinia viruses 18 circulating in the wild in Brazil bears striking similarity to the Brazilian vaccine used for 19 systematic vaccination during the eradication campaign, produced in Rio de Janeiro (19) 20 and called strain IOC (10) . This similarity raises the interesting possibility that the 21 circulating vaccinia viruses represent feral derivatives of IOC or of a closely related 22 ancestor. Little is known about the sensitivity of these novel vaccinia viruses to antiviral 23 compounds. In the absence of an active smallpox vaccination campaign, the spread of these 24 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from RESULTS 1
Inhibition of CTGV and VACV-IOC progeny production by CDV 2
We have previously shown that CDV inhibited CTGV and VACV-IOC replication, 3 in low MOI (0.001) infections of BSC-40 cells. We have also shown that up to 632 µM 4 CDV was not toxic to the cells after 48 h of treatment (26) . In the present study, we 5 elevated the MOI to evaluate the stages of virus cycle. We first examined the effect of 6 different concentrations of CDV on the production of virus particles in BSC-40 cells after 7 24 h of infection. Figure 1A shows that the drug gradually inhibited CTGV progeny yield, 8 reaching a plateau >90% with an MOI of 5 and 65 µM CDV. Because the effect of CDV 9
has not been regularly analyzed with elevated MOI, no correlation with previous published 10 data could be inferred. Next, we performed a one-step growth assay and observed that 65 11 µM CDV progressively inhibited CTGV titers after 8 h of infection, reaching 12 approximately 10-fold reduction at 24 h (Fig. 1B) . Similar kinetics of virus production and 13 levels of yield inhibition in the presence of CDV were obtained for VACV-IOC (data not 14 shown). This effect was not reverted with the removal of CDV from cell culture nor 15 intensified with further addition of the drug to the culture medium at 8 hours of infection 16 (data not shown). Therefore, we chose the concentration of 65 µM CDV for all subsequent 17 experiments. 18 CDV effect on viral DNA replication, genome resolution and protein synthesis 19 CDV is reported to inhibit the activity of VACV DNA polymerase, and thus, it is 20 suggested that virus DNA replication is probably the main target of the drug (34). 21 Therefore, we examined virus DNA accumulation throughout infection in the presence of 22 CDV. Cells were infected with CTGV, treated with 65 µM CDV and harvested at the 23 indicated times postinfection for slot-blot hybridization. Figure 2A shows that virus DNA 24 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from 13 accumulated with the progression of infection in untreated infected cells. Interestingly, the 1 presence of CDV during infection inhibited virus DNA synthesis slightly, reaching nearly 2 30% reduction at 24 h postinfection ( Fig. 2A) , although virus yields were inhibited >90% 3 under identical experimental conditions (Fig. 1) . Similar results were obtained when 4 analyzing the time-course accumulation of VACV-IOC DNA during infection in the 5 presence of CDV (data not shown). Increasing concentrations of CDV did not alter these 6 results (data not shown). 7
Genome resolution is a crucial step for the completion of VACV replicative cycle. 8
As a result of the DNA replication process, concatemeric genome structures are formed and 9 resolved into monomeric molecules with the aid of the virus resolvase A22. The single 10 genome unit is then packaged into the virus particle (20, 36, 40) . To investigate whether 11 CDV treatment inhibited virus telomere resolution, total DNA was extracted from infected 12 BSC-40 cells, and analyzed by Southern blot hybridization. Figure 2B were then analyzed by SDS-PAGE. In untreated cells infected with CTGV (Fig. 3A) or 3 VACV-IOC (data not shown), virus proteins were initially detected at 4 h, and the synthesis 4 of late polypeptides progressed at approximately the same rate until 24 h postinfection. In 5 the presence of CDV, similar protein profiles were detected throughout infection, revealing 6 that the synthesis of virus polypeptides was unaffected by the drug. The proteolytic cleavage of some VACV core proteins is required for successful 18 virus morphogenesis, and its failure arrests the transition from IV to MV particles (8, 37, 19 38, 51) . To evaluate the effect of CDV on the processing of the precursors p4a and p4b, we 20 performed pulse-chase assays in cells infected with CTGV ( was clearly detected after 3 h of chase. Nevertheless, when virus infection proceeded in the 1 presence of CDV, the precursors still accumulated during the chase period, and the 2 detection of the mature proteolytic products 4a and 4b was severely reduced (Fig. 3B) . 3
Longer chase periods generated similar results (data not shown). The proteolytic processing 4 of the VACV-WR major core proteins was also inhibited by CDV treatment, as detected by 5 the inhibition of p4a and p4b cleavage and diminished accumulation of the mature forms 4a 6 and 4b relative to untreated cells in Western blots assays (data not shown). As a negative 7 control ( Fig. 3C ), pulse-chase assays were carried out in CTGV-infected cells treated with 8 rifampicin, which inhibits VACV proteolytic processing (38, 51) . Although the effect of 9 CDV was not as dramatic as the action of rifampicin, it clearly indicated that CDV affected 10 the proteolytic processing of core protein precursors and that virus assembly could be 11 compromised. 12
CTGV and VACV-IOC morphogenesis is arrested in the presence of CDV 13
The progression of the morphogenetic process may be monitored by transmission 14 electron microscopy. Therefore, to gain insight into the generation of CTGV and VACV-15 Fig. 5B to 5F ). We also 1 observed several structures resembling DNA crystalloids with an internal striated aspect 2 ( Fig. 5G and 5H) . In some sections, we detected abnormal circular membrane elements 3 distinct from typical crescents associated with the periphery of the virosomes (Fig. 5I) . 4
Quantitative analysis of approximately 30 random fields in three independent assays 5 revealed that in the presence of CDV the number of MV was reduced nearly 2.4-fold and 6 3.5-fold in CTGV and VACV-IOC infected cells, respectively, when compared with 7 untreated cells (Table 1) . In parallel, the number of total immature particles increased 8 approximately 3.2-fold in CDV-treated cells infected with both viruses. Although IVN 9
were more abundant in the presence than in the absence of CDV, the ratio of IVN to IV 10 decreased in CDV-treated cells. In untreated cells, we detected nearly 1.55 IVN per 10 IV 11 for both viruses. However, in the presence of CDV, the ratio was approximately 0.9 IVN 12 per 10 IV. 13
Analysis of CTGV virions isolated from CDV-treated cells 14
To further investigate the effect of CDV on the formation of virus particles, we 15 purified virions from CTGV-infected cells untreated or treated with CDV for 24 h, and 16 examined particles for morphology, yield, protein, and DNA content. To analyze particle 17 morphology, purified viruses were processed for TEM. Figure 6 shows that control virus 18 comprised mainly mature forms ( Samples of control and CDV viruses were equalized by protein concentration and 3 resolved by SDS-PAGE, followed by coomassie-blue staining (Fig. 7A) . Despite the 4 differences observed in virus forms in the presence of CDV, protein profiles were quite 5 similar, except that the accumulation of mature forms of the core proteins 4a and 4b 6 appeared less intense in CDV virus than in control virus (Fig. 7A) . To examine the 7 presence of specific membrane and core proteins, we analyzed 16 viral proteins by Western 8 blot. The results shown in Fig. 7B revealed no major differences between control and CDV 9 viruses, with the notable exception of the major core proteins p4a and p4b, which showed 10 increased amounts of the precursor forms in CDV virus relative to control virus. This effect 11 was particularly evident for p4b. 12
The encapsidation of virus DNA in control and CDV virus particles was quantitated 13 by slot blot hybridization. Equal amounts of protein of purified viruses were applied onto 14 duplicate membranes. One replica was hybridized to a radiolabeled VACV HindIII D 15 fragment DNA probe while the other was processed for Western blot analysis to detect 16 VACV structural proteins, used as loading control. As shown in Fig. 7C Together, these data strongly suggest that the inhibitory effects of CDV on VACV 5 genome encapsidation and proteolytic processing were not caused by a direct action of the 6 drug on virus morphogenesis. Instead, it resulted from a primary effect of CDV at an earlier 7 stage of infection, probably DNA synthesis, leading to major defective phenotypes on the 8 later stage of virus assembly. This is particularly interesting in light of the fact that CDV 9 only slightly inhibited VACV DNA replication and did not affect genome resolution and 10 late gene expression. 11
Analysis of VACV DNA structure by AFM 12
To gain insight into VACV genome produced in the absence or presence of CDV, 13
we evaluated the structure of virus DNA by AFM, which has been extensively used to 14 elucidate conformational changes of nucleic acids (32). Because CDV inhibited DNA 15 encapsidation into virus particles, we chose to initiate our analysis investigating total virus 16 DNA generated during infection and isolated from the cytoplasm of infected cells. VACV-WR 24 h was gently isolated and prepared for AFM imaging. All images were 22 acquired using Mg 2+ to adsorb the DNA onto mica substrate (9). 23 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from Figure 9 shows that cytoplasmic DNA from untreated infected cells formed highly 1 organized DNA networks (Fig. 9A, star) , which were observed in all images obtained from 2 distinct DNA preparations (detail in Fig. 9B, star) . In addition, stretched segments of DNA 3 were noticed (Fig. 9A, white arrowhead) . Network structures have been frequently reported 4 in studies with different types of DNA (small or long, linear or circular molecules), and 5 DNA concentration and size are important factors. Networks are formed during sample 6 deposition onto substrate under several experimental conditions, particularly with the use of 7 bivalent cations, which act as positively charged bridges between the negatively charged 8 mica substrate and negatively charged DNA strands as well as between DNA strands. 9
Therefore, DNA networks do not represent an array of concatemers but refer to an 10 arrangement of layers of tangled DNA strands overlapping each other when placed on 11
proper substrates (31, 41, 54, 56) . In our assays, sample dilution decreased the formation of 12 network (data not shown). Nevertheless, it also reduced the probabilities of finding a 13 significant number of single DNA molecules and then observe representative DNA 14
structures. 15
Similar network structures along with stretched segments of DNA were also 16 observed in images of cytoplasmic DNA from infected cells treated with CDV (Fig. 9C,  17 star and white arrowhead, respectively). Nevertheless, besides the formation of DNA 18 network, we also observed DNA aggregates with disordered arrangements and increased 19 entanglements, showing intense and disorganized strand overlapping and interwinding ( (Fig. 9D and 9G,  2 arrows), and 1.5 nm to 2 nm and sometimes 6 nm (Fig. 9E, 9F and 9H, arrows) , suggesting 3 intense strand overlapping. These measurements indicate structural changes in the DNA 4 associated with unusual aggregated forms instead of the classical network formation. 5
The cell fractioning procedure used to isolate VACV DNA from the cytoplasm 6 probably leads to co-sedimentation of mitochondria as well. Thus, as controls, we analyzed 7 cytoplasmic DNA obtained from uninfected cells untreated or treated with CDV. We rarely 8 detected DNA in either sample after several imaging attempts ( Fig. 9I and 9J, white 9 arrowheads), supporting the conclusion that the DNA images acquired from samples of 10 infected cells corresponded to viral DNA. To evaluate whether the DNA aggregates were 11 encapsidated into virus particles during morphogenesis, we analyzed DNA extracted from 12 purified virions isolated from cells untreated or treated with CDV. Figures 9K and 9L show 13 that both samples of DNA extracted from purified virus particles had similar and unaltered 14 structure of characteristic DNA network (stars). Aberrant DNA aggregates were not 15 detected in distinct assays. Therefore, our data indicate that virus DNA synthesized in the 16 presence of CDV had an altered structure, forming aggregations that were not encapsidated 17 into virus particles but remained in the cytoplasm of infected cells treated with CDV. Several in vitro studies with purified DNA polymerase of HCMV and VACV (33, 34, 55), 3 and in vivo studies with CDV-resistant viruses (2, 5, 28, 45) have pointed to virus DNA 4 replication as the main target for CDV action. However, a detailed analysis of the effect of 5 CDV on VACV replicative cycle has never been reported. In this study, we evaluated the 6 VACV cycle in BSC-40 cells infected at an MOI of 5 in the presence of CDV. 7
Interestingly, although we detected 1-log inhibition of virus titers, DNA replication was 8 reduced by only 30%, and no significant effect on genome resolution and post-replicative 9 protein synthesis was observed. However, virus MOI as low as 0.001 leads to levels of 10 DNA synthesis inhibition > 90% (26). These contrasting effects dependent on virus MOI 11 may be possibly explained in light of previous data of Magee and co-workers (33) showing 12 that CDV, a non chain-terminating analogue, inhibited VACV DNA polymerase more 13 severely when incorporated into the template strand, mostly affecting secondary rounds of 14 DNA synthesis. Thus, the outcome of this effect on virus DNA replication is expected to be 15 more pronounced when virus MOI is very low and few copies of input genome are 16 available for the onset of DNA synthesis. indicated that the number of MV particles decreased significantly when CDV was present, 7 concurrent with an increase of immature forms of CTGV. Abnormal IV, including dense 8 spherical particles, were consistently observed, resembling aberrant forms described during 9 the infection with VACV mutants with defect in the expression of I7, D6, A32, A4, A10, 10 J1, I6, G7, and A13. Some of these mutants are deficient in the proper formation of IV (3, 11 6, 7, 17, 22, 23, 25, 27, 47, 50, 53) . Importantly, DNA crystalloids were also detected in 12 cells infected in the presence of CDV, and the relative number of IVN to total IV 13 decreased. Correspondingly, the DNA content of purified VACV particles isolated from 14 CDV-treated cells was approximately 35% of that detected in virions purified from 15 untreated cells. 16
Our data indicate that essential processes of VACV morphogenesis were affected in 17 CDV-treated cells in a fashion that could be correlated with the overall inhibition of VACV 18 replication. However, we also show that CDV did not directly impair VACV 19 morphogenesis when added after virus DNA has accumulated to sufficient levels. 20 Therefore, our results suggest that the presence of CDV in the DNA strands probably led to 21 the later defects observed in VACV morphogenesis. IVs were reported which possessed a distorted membrane contour and an asymmetrical 3 distribution of the internal eletron dense material. DNA crystalloids and numerous dense 4 spherical particles were also detected, similar to our findings in CDV-treated cells. Virus 5 particles had normal protein content and failed to encapsidate DNA. In addition, late 6 protein synthesis occurred at normal levels, genome resolution was not impaired, and the 7 proteolytic processing of virus major core proteins was inhibited (6, 22) . These features 8
were also observed in the presence of CDV. A13 is a membrane protein also apparently 9 involved in DNA encapsidation. Repression of A13 expression led to the appearance of 10 DNA crystalloids and abnormal circular membrane structures surrounding the virosomes 11 (50), resembling the structures shown in the present work. 12
It is tempting to hypothesize that CDV may act by affecting DNA structure and thus 13 preventing genome packaging. Little is known about the relevance of DNA structure for the 14 accurate encapsidation of viral genomes. Studies on the DNA packaging process are mostly 15 reported for dsDNA bacteriophages, HSV-1, and adenovirus, mainly focusing on cis-acting 16 sequences and viral packaging proteins (21, 43, 57) . However, it has been shown that the 17 HSV-1 pac1 sequence adopts novel DNA structures essential for its recognition by the 18 packaging protein U L 28 (1). A model for VACV DNA encapsidation was proposed by 19 Grubisha and Traktman (22) Alterations in DNA structure caused by incorporation of CDV have not been 3 reported previously. Nevertheless, it has been shown that the absence of the deoxyribose 4 sugar ring in another acyclic nucleoside phosphonate, tenofovir, makes it more flexible than 5 regular nucleoside analogs, and its incorporation at the end of primers induces 6 conformational changes in tenofovir and, consequently, into primer structure (49). 7 AFM has proved to be a powerful tool to study morphological changes on DNA 8 structure, such as formation of knots, kinks, supercoils and bends (32). Here, our AFM 9 images revealed crucial differences in the structure of VACV DNA isolated from the 10 cytoplasm of untreated or CDV-treated cells. In untreated cells, cytoplasmic viral DNA 11 formed organized network structures of tangled strands, which were likely to occur due to 12 the long VACV genome size, approximately 68 µm (8). The formation of DNA networks 13 and mesh size in AFM have been shown to be dependent on the concentration/type of 14 bivalent cations, type of solid substrate, DNA concentration, and DNA size. Under similar 15 conditions of sample preparation, the formation of regular networks of oligonucleotides 16 require around 125 µg/ml of DNA, whereas for plasmids and linear lambda DNA (48.5 kb), 17 approximately 70 ng/ml and 20 ng/ml have been used, respectively (9, 31, 41, 54, 56) . 18 Therefore, based on its size, the use of VACV DNA at 5 ng/ml would be expected to form 19 networks. It is worth noting that formation of networks does not imply that virus DNA 20 molecules are concatemers. In fact, VACV genome was successfully resolved into 21 monomers under our experimental conditions as shown by Southern blot assays. indistinguishable from control DNA under our assay conditions. The DNA aggregations 4 represent important conformational distortions in DNA structure, but we cannot exclude the 5 occurrence of other minor, subtle conformational changes in DNA, not detected by our 6 experimental approach. However provocative, these initial data do not permit a causative 7 association between the alterations of DNA structure and the inhibition of virus DNA 8 encapsidation during CDV treatment. In addition, we cannot exclude the possibility that the 9 slight inhibition of DNA replication by CDV could lead to minor defects in late protein 10 synthesis below the level of detection by pulse-labeling assays, and that could affect virus 11 morphogenesis in an important way. However, the encouraging AFM evidence supports the 12 previous hypothesis and is worth further investigation. 13
As mentioned before, previous studies have pointed to the process of DNA 14 replication as the target for CDV inhibitory activity. On the other hand, our data revealed 15 that CDV only slightly affected DNA replication during infection but, instead, virus 16 morphogenesis was significantly impaired. These apparently contradictory findings 17 regarding CDV mechanism of action could be reconciled by our results showing an 18 important inhibition of virus DNA encapsidation. These effects, however, resulted from a 19 primary action of CDV on DNA synthesis. Therefore, in sum, we suggest that the 20 incorporation of CDV into DNA molecules by the viral DNA polymerase would be the first 21 
